|
1 Indications And Usage Imlygic Is A Genetically Modified Oncolytic Viral Therapy Indicated For The Local Treatment Of Unresectable Cutaneous, Subcutaneous, And Nodal Lesions In Patients With Melanoma Recurrent After Initial Surgery. Limitations Of Use : Imlygic Has Not Been Shown To Improve Overall Survival Or Have An Effect On Visceral Metastases. Imlygic Is A Genetically Modified Oncolytic Viral Therapy Indicated For The Local Treatment Of Unresectable Cutaneous, Subcutaneous, And Nodal Lesions In Patients With Melanoma Recurrent After Initial Surgery. Limitations Of Use : Imlygic Has Not Been Shown To Improve Overall Survival Or Have An Effect On Visceral Metastases. ( 1 )
|